What is the appropriate dosage of ashwagandha for treating anxiety?

Ashwagandha Dose for Anxiety

For anxiety management in adults, ashwagandha root extract should be dosed at 300-600 mg daily (standardized to contain withanolide glycosides), typically divided into two doses (e.g., 300 mg twice daily), for a minimum of 8 weeks.

Evidence-Based Dosing Recommendations

The most robust recent evidence supports the following dosing strategy:

Standard Effective Dose

• 300 mg twice daily (600 mg/day total) is the most consistently effective dose across multiple high-quality trials 1, 2, 3
• This dose should be standardized to contain 2.5-35% withanolide glycosides depending on the extract concentration
• Treatment duration should be at least 8 weeks for optimal anxiety reduction 2, 4

Alternative Dosing Options

Lower dose option:

• 250 mg daily (125 mg twice daily) has shown significant anxiety reduction in stressed adults 3
• Even 30-60 mg daily of high-concentration extracts (35% withanolide glycosides) demonstrated efficacy 5, 6

Higher dose considerations:

• Doses up to 2000 mg daily have been studied and found safe, though not necessarily more effective 7
• The dose-response meta-analysis suggests optimal effects occur at 300-600 mg/day, with diminishing returns beyond 12,000 mg/day 1

Clinical Implementation

Starting regimen:

1. Begin with 300 mg twice daily (morning and evening) of standardized ashwagandha root extract
2. Take with meals to minimize gastrointestinal side effects
3. Continue for minimum 8 weeks before assessing full therapeutic effect
4. Effects on cortisol and anxiety symptoms typically emerge within 4-8 weeks 2, 4

Monitoring parameters:

• Assess anxiety symptoms at baseline, 4 weeks, and 8 weeks using validated scales (HAM-A or GAD-7)
• Monitor for mild gastrointestinal effects (nausea occurs in ~5.5% of patients) 7
• If using doses >1000 mg/day, monitor thyroid function and liver enzymes, though clinically significant changes are rare 7

Important Clinical Considerations

Contraindications and cautions:

• Ashwagandha is not recommended during pregnancy (similar precautions as other herbal supplements)
• Use caution with thyroid medications, as ashwagandha may affect thyroid hormone levels 7
• No significant drug interactions have been documented in clinical trials, but theoretical interactions with sedatives and anxiolytics should be considered

Comparative context: While established guidelines recommend SSRIs and SNRIs as first-line pharmacotherapy for anxiety disorders 8, ashwagandha represents an evidence-based complementary option, particularly for individuals with mild-to-moderate stress and anxiety who prefer herbal interventions or cannot tolerate conventional medications. The effect sizes for anxiety reduction with ashwagandha (SMD: -1.55 to -6.87) 1, 9 are clinically meaningful, though direct head-to-head comparisons with SSRIs are lacking.

Quality and standardization:

• Ensure the product is standardized for withanolide content (typically 2.5-5% for standard extracts, up to 35% for concentrated extracts)
• Higher withanolide concentrations allow for lower total daily doses while maintaining efficacy 5
• The addition of piperine (5 mg) may enhance bioavailability 4